🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/10/2007 17,46 18,84 17,16 18,42 +4,78% 9,62% 156.367
08/10/2007 17,04 17,76 16,74 17,58 +3,53% 5,99% 110.850
05/10/2007 15,42 17,04 15,36 16,98 +10,98% 10,89% 141.533
04/10/2007 15,36 15,72 15,30 15,30 -1,16% 2,73% 29.433
03/10/2007 15,12 15,66 15,12 15,48 +1,98% 3,57% 21.650
02/10/2007 15,24 15,54 15,06 15,18 -1,17% 3,15% 37.983
01/10/2007 15,24 15,48 15,24 15,36 +0,39% 1,57% 20.567
28/09/2007 15,36 15,54 15,30 15,30 -0,39% 1,56% 22.050
27/09/2007 15,36 15,66 15,36 15,36 -0,78% 1,95% 21.000
26/09/2007 15,30 15,72 15,30 15,48 +0,78% 2,75% 21.317
25/09/2007 15,36 15,78 15,30 15,36 -1,16% 3,12% 18.767
24/09/2007 15,78 16,08 15,42 15,54 -2,26% 4,18% 38.983
21/09/2007 16,02 16,32 15,78 15,90 -1,49% 3,37% 72.717
20/09/2007 16,02 16,44 15,78 16,14 +0,75% 4,12% 20.567
19/09/2007 16,26 16,50 15,90 16,02 +0,00% 3,69% 33.733
18/09/2007 15,84 16,38 15,84 16,02 +1,14% 3,41% 34.083
17/09/2007 16,38 16,44 15,72 15,84 -4,35% 4,40% 22.500
14/09/2007 15,60 16,56 15,60 16,56 +4,15% 6,15% 32.167
13/09/2007 16,08 16,20 15,60 15,90 -1,12% 3,73% 28.650
12/09/2007 16,20 16,44 15,90 16,08 +3,88% 3,33% 85.283
11/09/2007 15,48 15,60 15,30 15,48 +0,00% 1,94% 38.583
10/09/2007 16,14 16,14 15,42 15,48 -4,09% 4,46% 32.600
07/09/2007 15,60 16,14 15,54 16,14 +2,28% 3,85% 26.533
06/09/2007 15,60 15,90 15,60 15,78 +1,15% 1,92% 14.550
05/09/2007 15,96 16,02 15,48 15,60 -2,26% 3,38% 17.400
04/09/2007 15,30 15,96 15,30 15,96 +1,92% 4,31% 27.333
31/08/2007 15,90 15,90 15,24 15,66 +0,00% 4,15% 39.783
30/08/2007 15,60 16,14 15,60 15,66 -1,14% 3,46% 63.500
29/08/2007 15,42 15,84 15,30 15,84 +2,72% 3,50% 30.433
28/08/2007 15,72 15,78 15,12 15,42 -1,53% 4,20% 41.417